BioSpace News Archive

Informa Markets is launching an annual dedicated online platform for pharma in May (17-28th), CPhI Discover – designed to encourage suppliers and customers to source, meet and discover – providing the industry with a new synergistic offering to sit alongside CPhI’s portfolio of in person events.

American Rheumatology Network (ARN), in partnership with Trio Health, launched ARN Clinical Research to transform drug development for rheumatology research

Prescription drug prices in Canada are among the highest in the developed world. Canada’s patchwork of drug coverage leaves many Canadians facing significant barriers to getting the prescription drugs they need.

Cell Source, Inc. (OTC: CLCS) (“Cell Source” or “the Company”), is the world leader in Veto Cell based innovative immunotherapy and today announced that Darlene Soave has been appointed to the Company’s Board of Directors, effective May 25, 2021.

MilliporeSigma, a leading provider of functional genomics screening and genome- editing tools, has launched its CRISPR inhibition (CRISPRi) whole-genome libraries and pools to complement its industry-leading suite of genome-editing products and technologies.

Nine esteemed ophthalmologists at Bascom Palmer Eye Institute were selected for The Ophthalmologist Power List 2021, which honors the world’s 100 most influential women in the field of ophthalmology.

“The strategic divestment of our Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, announced that on March 31, 2021, the Company granted stock options and restricted stock units to three new employees of the Company.

Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report first quarter 2021 financial results on Wednesday, April 28, 2021, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Company’s website at http://investor.aligntech.com .

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial results on Thursday, April 29, 2021, prior to its earnings call at 8:00 a.m. ET.